Ribotypes and antimicrobial susceptibility profiles of clinical Clostridioides difficile isolates: A multicenter, laboratory-based surveillance in Taiwan, 2019-2021

Tsai, Chin-ShiangChin-ShiangTsaiLu, Po-LiangPo-LiangLuLu, Min-ChiMin-ChiLuHsieh, Tai-ChinTai-ChinHsiehChen, Wei-TingWei-TingChenJANN-TAY WANGKo, Wen-ChienWen-ChienKo2024-03-062024-03-062024-0416841182https://scholars.lib.ntu.edu.tw/handle/123456789/640420The clinical burden of Clostridioides difficile infections (CDIs) remains substantial globally. This study aimed to investigate the ribotypes (RTs) and antimicrobial susceptibility of C. difficile isolates collected in Taiwan.enAntimicrobial susceptibility; Clostridioides (Clostridium) difficile; Fidaxomicin; RibotypeRibotypes and antimicrobial susceptibility profiles of clinical Clostridioides difficile isolates: A multicenter, laboratory-based surveillance in Taiwan, 2019-2021journal article10.1016/j.jmii.2023.12.004381356462-s2.0-85180587989https://api.elsevier.com/content/abstract/scopus_id/85180587989